COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 1966: Articles 19651-19660  | Next

Online biophysical predictions for SARS-CoV-2 proteins
Kagami, L., Martinez, J. R., Garcia, J. G., Ramasamy, P., Feenstra, K. A. A., Vranken, W. F.
10.1101/2020.12.04.411744 — Posted: 2020-12-05
Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity
Giroux, N. S., Ding, S., McClain, M. T., Burke, T. W., Petzold, E. W., Chung, H. A., Palomino, G. R., Wang, E., Xi, R., Bose, S., Rotstein, T., Nicholson, B. P., Chen, T., Henao, R., Sempowski, G. D., Denny, T. N., Ko, E. R., Ginsburg, G. S., Kraft, B. D., Tsalik, E. L., Woods, C. W., Shen, X.
10.1101/2020.12.04.412155 — Posted: 2020-12-05
Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro
Unal, M. A., Bitirim, C. V., Summak, G. Y., Bereketoglu, S., Cevher Zeytin, I., Besbinar, O., Gurcan, C., Aydos, D., Goksoy, E., Kocakaya, E., Eran, Z., Murat, M., Demir, N., Somers, J., Demir, E., Nazir, H., Ozkan, S. A., Ozkul, A., Azap, A., Yilmazer, A., Akcali, K. C.
10.1101/2020.12.04.410092 — Posted: 2020-12-05
Quality of life and depressive symptoms among Peruvian university students during the COVID-19 pandemic
Figueroa-Quinones, J., Ipanaque-Zapata, M., Machay-Pak, D., Rodriguez-Ruiz, J.
10.1101/2020.12.04.411330 — Posted: 2020-12-04
Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of the induction of IFN-mediated innate immune defences
Herder, V., Dee, K., Wojtus, J., Goldfarb, D., Rozario, C., Gu, Q., Jarrett, R., Epifano, I., Stevenson, A., McFarlane, S., Stewart, M., Szemiel, A., Pinto, R., Masdefiol Garriga, A., Graham, S., Murcia, P., Boutell, C.
10.1101/2020.12.04.411389 — Posted: 2020-12-04
Mental health problems in the general population during and after the first lockdown phase due to the SARS-Cov-2 pandemic: Rapid review of multi-wave studies
Richter, D., Riedel-Heller, S., Zuercher, S.
10.1101/2020.12.03.20243196 — Posted: 2020-12-04
First-described recently discovered non-toxic vegetal-derived furocoumarin preclinical efficacy against SARS-CoV-2: a promising antiviral herbal drug.
Galindo-Cardiel, I. J., Toledo Nunez, A., Celaya Fernandez, M., Ramirez Labrada, A., Uranga-Murillo, I., Arias Cabrero, M., Pardo, J., Panzeri, E.
10.1101/2020.12.04.410340 — Posted: 2020-12-04
OpenSAFELY: impact of national guidance on switching from warfarin to direct oral anticoagulants (DOACs) in early phase of COVID-19 pandemic in England
Curtis, H. J., MacKenna, B., Walker, A. J., Croker, R., Mehrkar, A., Morton, C. E., Bacon, S., Hickman, G., Inglesby, P., Bates, C., Evans, D., Ward, T., Cockburn, J., Davy, S., Bhaskaran, K., Schultze, A., Rentsch, C. T., Williamson, E., Hulme, W., McDonald, H. I., Tomlinson, L., Mathur, R., Drysdale, H., Eggo, R. M., Wing, K., Wong, A., Forbes, H., Parry, J., Hester, F., Harper, S., Evans, S. J., Douglas, I. J., Smeeth, L., Goldacre, B.
10.1101/2020.12.03.20243535 — Posted: 2020-12-04
Spatial risk factors for Pillar 1 COVID-19 case counts and mortality in rural eastern England, UK
Brainard, J. S., Rushton, S., Winters, T., Hunter, P. R.
10.1101/2020.12.03.20239681 — Posted: 2020-12-04
Surgery & COVID-19: A rapid scoping review of the impact of COVID-19 on surgical services during public health emergencies
O'Rielly, C., Ng Kamstra, J., Kania-Richmond, A., Dort, J. C., White, J., Robert, J., Brindle, M., Sauro, K. M.
10.1101/2020.12.03.20243592 — Posted: 2020-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).